Biotech company focusing on cell growth raises $42M

Biotech company Prolific Machines has raised $42 million in seed and series A funding rounds.

Advertisement

Prolific Machines is working to create a scalable assembly line process for biotech innovations. Prolific Machines’ initial focus will be on creating cultured meat; however, the technology is cell-agnostic. This means it can be used for a variety of biotech applications, according to the Sept. 14 Prolific news release.

The series A funding round was led by Bill Gates-founded Breakthrough Energy Ventures. Arvind Gupta at Mayfield led the seed funding round.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.